What's New

STUART SENDER SPOKE AT THE BIO CONFERENCE IN SAN FRANCISCO ON JUNE 8

Stuart Sender spoke at the BIO Conference in San Francisco on June 8. His topic was "The Battle for IP: Innovators vs. Generic Drug Makers" . He discussed some of the recent court decisions and regulatory trends that are influencing the product life-cycle management landscape, focusing in particular on opportunities and threats in drug substance IP for pharmaceutical and biotech companies.